Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01808352 · ClinicalTrials.gov registry record

HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)

A clinical trial, sponsored by HIV Prevention Trials Network.

Completed
Registry status
226
Enrollment target

NCT01808352: Completed study, sponsored by HIV Prevention Trials Network.

NCT01808352 is a clinical trial that has completed, run by HIV Prevention Trials Network. The registered enrollment target is 226 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01808352 has completed, sponsored by HIV Prevention Trials Network.

COMPLETED
Registry status
226 participants
Enrollment target

Study Summary

Black men who have sex with men (MSM) Pre-Exposure Prophylaxis (PrEP) Study with Client Centered Care Coordination (C4) Component.

Primary Outcome

Documented in either study CRFs or ACASI

Interventions

  • OTHER Observational

Trial Details

FieldValue
Enrollment Target 226 participants
Start Date 2013-08-15
Est. Completion 2015-09-30
HIV Prevention Trials Network

10 total trials

What the finished NCT01808352 record still lists

NCT01808352 is an observational study that tracks outcomes without assigning an intervention. The registered 226 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.

NCT01808352 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01808352 about?

NCT01808352 is a clinical study titled "HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)". Black men who have sex with men (MSM) Pre-Exposure Prophylaxis (PrEP) Study with Client Centered Care Coordination (C4) Component.

What is the current status of trial NCT01808352?

This trial is currently completed. The enrollment target is 226 participants. The study started on 2013-08-15. Estimated completion is 2015-09-30.

What interventions are being tested in trial NCT01808352?

The interventions under investigation include: Observational (OTHER).

Who is sponsoring clinical trial NCT01808352?

This trial is sponsored by HIV Prevention Trials Network, which has 10 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04419272 · 226 participants · Phase 4

    Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

  • NCT05449002 · 226 participants · NA

    Digital Single Session Intervention for Youth Mental Health

  • NCT05488054 · 226 participants · NA

    Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery

  • NCT05924477 · 226 participants · NA

    Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01808352, the US trial registry maintained by the National Library of Medicine. NCT01808352 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.